Philippines

Metro Drug Inc

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Drugs and Druggists' Sundries Merchant Wholesalers Available in: English Format: PDF Download Most recent financial data: 2015 Buy full report

What’s included?

This report extracts all available information about Metro Drug Inc from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
Manalac Avenue Taguig City
Taguig; National Capital Region; Map
Postal Code: 1631

Tel: (02) 802

Company Description
Metro Drug Inc. is in the business of distribution of pharmaceutical and healthcare products in the Philippines. The company was incorporated in 1931 and is based in Taguig City.
NAICS Industry Classification
Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Basic Information
Financial Auditors:
()
Profile Updated:
October 24, 2017
Key Executives
President
Vice President
Key Financial Highlights
2015 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 7,972,039
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: CIBI Information Inc, EMIS Company Database.
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score

Latest News (Not included in the report)

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO